Columbia Asset Management Amgen Inc Transaction History

Columbia Asset Management

$574 Million
Q3 2024

A detailed history of Columbia Asset Management transactions in Amgen Inc stock. As of the latest transaction made, Columbia Asset Management holds 23,072 shares of AMGN stock, worth $6.8 Million. This represents 1.3% of its overall portfolio holdings.

Number of Shares

23,072

Previous 22,961 0.48%

Holding current value

$6.8 Million

Previous $7.17 Million 3.62%

% of portfolio

1.3%

Previous 1.34%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$309.38 - $337.38 $34,341 - $37,449	111 Added 0.48%	23,072 $7.43 Million
Q2 2024 Aug 05, 2024	BUY	$262.75 - $319.31 $470,848 - $572,203	1,792 Added 8.47%	22,961 $7.17 Million
Q4 2023 Feb 09, 2024	SELL	$255.7 - $288.46 $511 - $576	-2 Reduced 0.01%	21,169 $6.1 Million
Q3 2023 Nov 13, 2023	BUY	$218.65 - $271.46 $57,723 - $71,665	264 Added 1.26%	21,171 $5.69 Million
Q2 2023 Aug 14, 2023	SELL	$214.27 - $253.37 $61,495 - $72,717	-287 Reduced 1.35%	20,907 $4.64 Million
Q1 2023 May 15, 2023	BUY	$225.79 - $275.2 $130,958 - $159,616	580 Added 2.81%	21,194 $5.12 Million
Q4 2022 Feb 10, 2023	BUY	$229.03 - $291.01 $17,864 - $22,698	78 Added 0.38%	20,614 $5.41 Million
Q3 2022 Nov 03, 2022	BUY	$224.46 - $253.15 $26,261 - $29,618	117 Added 0.57%	20,536 $4.63 Million
Q2 2022 Aug 26, 2022	BUY	$230.71 - $256.74 $375,595 - $417,972	1,628 Added 8.66%	20,419 $4.97 Million
Q4 2021 Feb 14, 2022	BUY	$198.88 - $227.6 $149,955 - $171,610	754 Added 4.18%	18,791 $4.23 Million
Q3 2021 Nov 15, 2021	BUY	$212.27 - $248.7 $43,515 - $50,983	205 Added 1.15%	18,037 $3.84 Million
Q2 2021 Aug 02, 2021	SELL	$233.58 - $259.14 $1.49 Million - $1.65 Million	-6,365 Reduced 26.3%	17,832 $4.35 Million
Q1 2021 May 28, 2021	BUY	$221.91 - $258.6 $7,766 - $9,051	35 Added 0.14%	24,197 $6.02 Million
Q4 2020 Feb 11, 2021	SELL	$216.38 - $257.67 $105,809 - $126,000	-489 Reduced 1.98%	24,162 $5.56 Million
Q3 2020 Nov 16, 2020	SELL	$234.65 - $260.95 $1.1 Million - $1.22 Million	-4,678 Reduced 15.95%	24,651 $6.27 Million
Q2 2020 Aug 14, 2020	BUY	$197.81 - $242.74 $106,817 - $131,079	540 Added 1.88%	29,329 $6.92 Million
Q1 2020 May 14, 2020	BUY	$182.24 - $241.7 $75,811 - $100,547	416 Added 1.47%	28,789 $5.84 Million
Q4 2019 Feb 14, 2020	BUY	$189.21 - $243.2 $84,387 - $108,467	446 Added 1.6%	28,373 $68.4 Million
Q3 2019 Nov 12, 2019	BUY	$174.11 - $208.62 $135,805 - $162,723	780 Added 2.87%	27,927 $5.4 Million
Q2 2019 Aug 15, 2019	SELL	$166.7 - $195.41 $194,372 - $227,848	-1,166 Reduced 4.12%	27,147 $5 Million
Q1 2019 May 20, 2019	SELL	$180.87 - $203.88 $45,579 - $51,377	-252 Reduced 0.88%	28,313 $5.38 Million
Q4 2018 Feb 12, 2019	SELL	$178.4 - $208.25 $61,191 - $71,429	-343 Reduced 1.19%	28,565 $5.56 Million
Q3 2018 Nov 06, 2018	BUY	$185.29 - $208.89 $193,072 - $217,663	1,042 Added 3.74%	28,908 $5.99 Million
Q2 2018 Aug 14, 2018	BUY	$166.05 - $186.51 $194,444 - $218,403	1,171 Added 4.39%	27,866 $5.14 Million
Q1 2018 May 07, 2018	BUY	$169.43 - $198.0 $92,508 - $108,108	546 Added 2.09%	26,695 $4.55 Million
Q4 2017 Feb 05, 2018	BUY	$168.79 - $188.59 $144,484 - $161,433	856 Added 3.38%	26,149 $4.55 Million
Q3 2017 Nov 07, 2017	BUY	$167.29 - $191.0 $4.23 Million - $4.83 Million	25,293	25,293 $4.72 Million

Others Institutions Holding AMGN

# of Institutions

3,122

Shares Held

410M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $158B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Columbia Asset Management, based on Form 13F filings with the SEC.

News

Stay updated on Columbia Asset Management with notifications on news.

Account

Columbia Asset Management Amgen Inc Transaction History